5148 related articles for article (PubMed ID: 2431329)
41. Ruthenium Red inhibition of in vitro lead effects on brain mitochondrial respiration.
Holtzman D; Obana K; Olson J
J Neurochem; 1980 Jun; 34(6):1776-8. PubMed ID: 6155445
[No Abstract] [Full Text] [Related]
42. Neomycin and ruthenium red antagonism of monoaminergic depression of cerebral cortical neurones.
Phillis JW
Life Sci; 1974 Jul; 15(2):213-22. PubMed ID: 4549912
[No Abstract] [Full Text] [Related]
43. Nematodirus battus: permeability changes, calcium binding, and phosphorylation of the eggshell during hatching.
Ash C; Atkinson HJ
Exp Parasitol; 1984 Aug; 58(1):27-40. PubMed ID: 6204883
[TBL] [Abstract][Full Text] [Related]
44. Formation and microscopical application of a fluorescent 1,10-phenanthroline derivative of ruthenium red.
Bertolesi GE; de Cidre LL; Stockert JC
Acta Histochem; 1995 Oct; 97(4):401-8. PubMed ID: 8607290
[TBL] [Abstract][Full Text] [Related]
45. Impairment by ruthenium red of anticancer drug cytotoxicity in CCRF-CEM cells.
Conter V; Beck WT
Biochem Pharmacol; 1983 Feb; 32(4):723-6. PubMed ID: 6187351
[No Abstract] [Full Text] [Related]
46. Ruthenium red binding to cell coat in neoplastic neurogenic cell lines in culture.
Haugen A
Virchows Arch B Cell Pathol; 1979 Feb; 29(4):245-52. PubMed ID: 105464
[TBL] [Abstract][Full Text] [Related]
47. Intramitochondrial binding of ruthenium red in degenerating chondroblasts.
Allenspach AL; Babiarz BS
J Ultrastruct Res; 1975 Jun; 51(3):348-53. PubMed ID: 48556
[No Abstract] [Full Text] [Related]
48. Microcirculatory and pH alterations in isotransplanted rat and xenotransplanted human tumors associated with hyperthermia.
Vaupel P; Kallinowski F; Kluge M; Egelhof E; Fortmeyer HP
Recent Results Cancer Res; 1988; 109():173-82. PubMed ID: 3175289
[No Abstract] [Full Text] [Related]
49. The use of synthetic nanometer pores for modeling the conduction block of cation-selective channels of cell membranes by ruthenium red.
Veinberg IO; Gotlib VA; Apel' PY; Lev AA
Dokl Biochem Biophys; 2005; 405():454-7. PubMed ID: 16480151
[No Abstract] [Full Text] [Related]
50. Electronmicroscopical detection of iota-carrageenan as its ruthenium red complex.
Timár J; Kopper L; Lapis K
Histochemistry; 1981; 72(1):101-6. PubMed ID: 6169688
[TBL] [Abstract][Full Text] [Related]
51. Development of early post-ischemic injury in the liver as evaluated by a double staining method combining an intravital dye exclusion test and alizarin red S.
Jennische E
Acta Pathol Microbiol Immunol Scand A; 1985 Nov; 93(6):359-65. PubMed ID: 2418631
[TBL] [Abstract][Full Text] [Related]
52. Changes in the cell coat of cultured human melanoma cells induced by hyperthermia--an ultrahistochemical study on ruthenium staining.
Liu YH
Acta Acad Med Wuhan; 1985; 5(4):197-200. PubMed ID: 2436123
[No Abstract] [Full Text] [Related]
53. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.
Cochran AJ; Wen DR; Morton DL
Am J Surg Pathol; 1988 Aug; 12(8):612-8. PubMed ID: 3041850
[TBL] [Abstract][Full Text] [Related]
54. Comparative analysis of clinicopathological and immunohistochemical characteristics of Merkel cell carcinoma.
Trenkic Bozinovic M; Krasic D; Katic V; Rancic D; Krstic M; Jocic Djordjevic J; Jovanovic J
J BUON; 2014; 19(2):530-4. PubMed ID: 24965417
[TBL] [Abstract][Full Text] [Related]
55. Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells.
Kaufmann R; Schafberg H; Rudroff C; Nowak G
Cancer; 1997 Dec; 80(11):2068-74. PubMed ID: 9392328
[TBL] [Abstract][Full Text] [Related]
56. Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo.
Kubota S; Ohsawa N; Takaku F
Int J Cancer; 1987 Feb; 39(2):244-7. PubMed ID: 3100460
[TBL] [Abstract][Full Text] [Related]
57. Viral oncolysates in cancer treatment: immunological mechanisms of action (review).
Ioannides CG; Platsoucas CD; O'Brian CA; Patenia R; Bowen JM; Wharton JT; Freedman RS
Anticancer Res; 1989; 9(3):535-44. PubMed ID: 2669619
[TBL] [Abstract][Full Text] [Related]
58. A combination of subcutaneous recombinant interleukin-2 and recombinant interferon-alpha in the treatment of advanced renal cell carcinoma or melanoma.
Vuoristo M; Jantunen I; Pyrhönen S; Muhonen T; Kellokumpu-Lehtinen P
Eur J Cancer; 1994; 30A(4):530-2. PubMed ID: 8018415
[TBL] [Abstract][Full Text] [Related]
59. Nevi and melanoma induced by chemical carcinogens in laboratory animals: similarities and differences with human lesions.
Pawlowski A; Lea PJ
J Cutan Pathol; 1983 Apr; 10(2):81-110. PubMed ID: 6406571
[TBL] [Abstract][Full Text] [Related]
60. [Distribution of DL-3 (3,4-dihydroxyphenyl)-alanine-2 C14 in the organism of mice with Cloudmann's S91 melanoma].
Delacretaz J; Emch M; Schellhorn JP
Arch Belg Dermatol Syphiligr; 1970; 26(2):261-70. PubMed ID: 5515554
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
